Zobrazeno 1 - 10 of 50 pro vyhledávání: '"S. Slot"'
1
The role of REBOA in patients in traumatic cardiac arrest subsequent to hemorrhagic shock: a scoping review
Autor: S A S, Slot, S E, van Oostendorp, L J, Schoonmade, L M G, Geeraedts
Publikováno v: European journal of trauma and emergency surgery : official publication of the European Trauma Society.
Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a useful adjunct in treatment of patients in severe hemorrhagic shock. Hypothetically, REBOA could benefit patients in traumatic cardiac arrest (TCA) as balloon occlusion of the aor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ec51825e6c0384b0790ad68fc05e48b6
https://pubmed.ncbi.nlm.nih.gov/36335515
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features
Autor: F. Bot, L. Braaf, Max Beijert, P. Gonzalez, Bauke Ylstra, S. Slot, O.B. Ponz, K. van Groningen, Margaretha G.M. Roemer, Annegien Broeks, Ron M. Kerkhoven, Oscar Krijgsman, D. de Jong
Publikováno v: Haematologica, 98(12), 1921-1929. Ferrata Storti Foundation
Krijgsman, O, Gonzalez, P, Ponz, O B, Roemer, M G M, Slot, S, Broeks, A, Braaf, L, Kerkhoven, R M, Bot, F, van Groningen, K, Beijert, M, Ylstra, B & de Jong, D 2013, ' Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features ', Haematologica, vol. 98, no. 12, pp. 1921-1929 . https://doi.org/10.3324/haematol.2013.085118
Haematologica, 98(12), 1921-1929. FERRATA STORTI FOUNDATION
Nodal marginal zone lymphoma is a poorly defined entity in the World Health Organization classification, based largely on criteria of exclusion and the diagnosis often remains subjective. Follicular lymphoma lacking t(14;18) has similar characteristi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::074121eaf3005d1f11cd9f9a87244924
https://doi.org/10.3324/haematol.2013.085118
Zobrazit plný text záznamu
4
Development of an MF patient reported outcome (PRO) tool for FDA qualification: Comprehensive literature search and physician cognitive debriefing results
Autor: H., Geyer, H., Kosiorek, A., Dueck, S., Slot, S., Zweegman, J.J., Kiladjian, P., Boekhorst, H., Schouten, F., Sackmann, A., Fuentes, D., Hernandez-Maraver, H., Pahl, F., Stegelmann, K., Doehner, K., Bonatz, A., Reiter, F., Boyer, G., Etienne, J.C., Ianotto, D., Ranta, L., Roy, J.Y., Cahn, C., Harrison, D., Radia, P., Muxi, N., Maldonado, C., Besses, F., Cervantes, P., Johansson, G., Barosi, F., Passamonti, B., Andreasson, J., Samuelsson, G., Birgegard, X., Sun, J., Xu, P., Zhang, Z., Xu, T., Barbui, Z., Senyak, M., Grieshammer, A., Rambaldi, M., Ferrari, T., Lehmann, R., Scherber, R., Mesa
Publikováno v: H., G, H., K, A., D, S., S, S., Z, J.J., K, P., B, H., S, F., S, A., F, D., H-M, H., P, F., S, K., D, K., B, A., R, F., B, G., E, J.C., I, D., R, L., R, J.Y., C, C., H, D., R, P., M, N., M, C., B, F., C, P., J, G., B, F., P, B., A, J., S, G., B, X., S, J., X, P., Z, Z., X, T., B, T., B, Z., S, M., G, A., R, M., F, T., L, R., S & R., M 2016, ' Development of an MF patient reported outcome (PRO) tool for FDA qualification: Comprehensive literature search and physician cognitive debriefing results ', Haematologica, vol. 101, pp. 564 . < http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L615559578 http://sfx.aub.aau.dk/sfxaub?sid=EMBASE&issn=15928721&id=doi:&atitle=Development+of+an+MF+patient+reported+outcome+%28PRO%29+tool+for+FDA+qualification%3A+Comprehensive+li >
Haematologica, 101. Ferrata Storti Foundation
Background: Myelofibrosis (MF) is recognized for its debilitating constitutional symptoms, splenomegaly, profound cytopenias and inflammatory state. Current MPN PROs (MF-SAF, MPN-SAF and MPN-10) have proven sensitive for symptom detection. Formal FDA
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ec56bdd330f96427d54a20493bc7ccda
https://research.vumc.nl/en/publications/e387e992-15eb-4a36-9779-458a6e8ea43b
Zobrazit plný text záznamu
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Effect of conditioning regimens on graft failure in myelofibrosis: a retrospective analysis
Autor: P. A. W. te Boekhorst, Reinier Raymakers, Birgit I. Witte, S. Slot, N W C J van de Donk, K. Smits, A.E.C. Broers, Jeroen Janssen, Sonja Zweegman
Publikováno v: Bone Marrow Transplantation, 50(11), 1424-1431. Nature Publishing Group
Slot, S, Smits, K, van de Donk, N W C J, Witte, B I, Raymakers, R, Janssen, J J W M, Broers, A E C, te Boekhorst, P A W & Zweegman, S 2015, ' Effect of conditioning regimens on graft failure in myelofibrosis: a retrospective analysis ', Bone Marrow Transplantation, vol. 50, no. 11, pp. 1424-1431 . https://doi.org/10.1038/bmt.2015.172
In myelofibrosis, the introduction of reduced- intensity conditioning (RIC) preceding allogeneic stem cell transplantation (SCT) resulted in lower transplant- related mortality rates compared with myeloablative conditioning. However, lowering the int
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27ad1c80e49b14fb8b82ddc47bfc1871
https://research.vumc.nl/en/publications/ff2a9876-7256-44ec-b679-7011f92d6151
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Conventional therapeutic options have limited impact on MPN symptoms: Insights from a prospective analysis of the MPN-SAF TSS
Autor: R., Scherber, A., Dueck, J., Kiladjian, S., Slot, S., Zweegman, P., Te Boekhorst, S., Commandeur, H., Schouten, F., Sackmann, A., Fuentes, D., Hernandez-Maraver, H., Pahl, M., Greiesshammer, F., Stegelmann, K., Doehner, T., Lehmann, K., Bonatz, A., Reiter, F., Boyer, G., Etienne, J., Ianotto, L., Roy, J., Cahn, C., Harrison, D., Radia, P., Muxi, N., Maldonado, C., Besses, F., Cervantes, P., Johansson, T., Barbui, G., Barosi, A., Vannucchi, F., Passamonti, B., Andreasson, M., Ferarri, A., Rambaldi, J., Samuelsson, G., Birgegard, A., Tefferi, R., Mesa
Publikováno v: R., S, A., D, J., K, S., S, S., Z, P., T B, S., C, H., S, F., S, A., F, D., H-M, H., P, M., G, F., S, K., D, T., L, K., B, A., R, F., B, G., E, J., I, L., R, J., C, C., H, D., R, P., M, N., M, C., B, F., C, P., J, T., B, G., B, A., V, F., P, B., A, M., F, A., R, J., S, G., B, A., T & R., M 2012, Conventional therapeutic options have limited impact on MPN symptoms: Insights from a prospective analysis of the MPN-SAF TSS . in Haematologica . Haematologica . < http://www.mendeley.com/research/conventional-therapeutic-options-limited-impact-mpn-symptoms-insights-prospective-analysis-mpnsaf-ts >
Haematologica
Background. Symptom burden in MPNs is severe and a risk factor for mortality in some disease subtypes (Blood 2010;115(9):1703-8). A recent trial comparing JAK2 treatment to best available therapy revealed that patients receiving conventional MPN ther
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d66f7a7562d5d45a9c8f15dc5386e47c
https://research.vumc.nl/en/publications/8d649bf5-ef74-49a7-bc13-92416e76797c
Zobrazit plný text záznamu
10
The Myleloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) Derived Total Symptom Score (TSS): An International Trial of 1433 Patients with Myeloproliferative Neoplasms (MPNs)
Autor: Karin Bonatz, Peter Johansson, Deepti Radia, Suzan Commandeur, Tiziano Barbui, Ayalew Tefferi, Dolores Hernández-Maraver, Lydia Roy, Amylou C. Dueck, Jan Samuelsson, Maria L Ferarri, Jean-Yves Cahn, Dana Ranta, Peter A. W. te Boekhorst, Gabriel Etienne, S. Slot, Giovanni Barosi, Heike L. Pahl, Thomas Lehmann, Norman Maldonado, Claire N. Harrison, Ana Kerguelen Fuentes, Bjorn Andreasson, Federico Sackmann, Alessandro M. Vannucchi, Carlos Besses, Françoise Boyer, R. Scherber, Pablo J. Muxi, Alessandro Rambaldi, Andreas Reiter, Francisco Cervantes, Harry C. Schouten, Jean-Christophe Ianotto, Martin Griesshammer, Frank Stegelmann, Sonja Zweegman, Gunnar Birgegård, Konstanze Doehner, Ruben A. Mesa, Jean-Jacques Kiladjian, Francesco Passamonti
Publikováno v: Scherber, R, Dueck, A, Kiladjian, J-J, Slot, S, Zweegman, S, te Boekhorst, P, Commandeur, S, Schouten, H C, Sackmann, F, Fuentes, A K, Hernandez-Maraver, D, Pahl, H L, Griesshammer, M, Stegelmann, F, Doehner, K, Lehmann, T, Bonatz, K, Reiter, A, Boyer, F, Etienne, G, Ianotto, J-C, Ranta, D, Roy, L, Cahn, J-Y, Harrison, C N, Radia, D, Muxi, P J, Maldonado, N I, Besses, C, Cervantes, F, Johansson, P, Barbui, T, Barosi, G, Vannucchi, A M, Passamonti, F, Andreasson, B, Ferarri, M L, Rambaldi, A, Samuelsson, J, Birgegard, G, Tefferi, A & Mesa, R A 2011, ' The Myleloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) Derived Total Symptom Score (TSS): An International Trial of 1433 Patients with Myeloproliferative Neoplasms (MPNs), ', Blood (ASH Annual Meeting Abstracts), vol. 118, no. 21, pp. 3839 . < http://abstracts.hematologylibrary.org/cgi/content/abstract/118/21/3839 >
Blood (ASH Annual Meeting Abstracts), 118(21)
Abstract 3839 BACKGROUND: We have previously reported on the validation of the 18 item Myeloproliferative Neoplasm Assessment Form (MPN-SAF) (Blood 2011;118:401–408) given in conjunction with the 9 item Brief Fatigue Inventory (BFI) (Cancer 1999;85
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de06ced0596c8801d9e67518eb8a84f4
https://research.vumc.nl/en/publications/b64a8524-ce1f-4228-b74a-a29921cdc16c
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje